Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Galena Biopharma GALE

Healthcare Biotechnology
"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive breast cancer."


NDAQ:GALE - Post by User

Galena Biopharma
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by EarningsImpact1on Jul 29, 2013 3:59am
231 Views
Post# 21635918

JMP-Securities-2013-Healthcare-Conference updates

JMP-Securities-2013-Healthcare-Conference updatesPriority is getting NeuVax approved and context for this is 210,000 women a year in US, will be newly diagnosed for breast cancer. [url=https://www.earningsimpact.com/Transcript/82090/GALE/Galena-Biopharma-Inc---JMP-Securities-2013-Healthcare-Conference]read here[/url]
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities